Plan Name [Axis] 2015 Long-term Incentive Plan [Member] Income Statement Location [Axis] General and Administrative Expense [Member] Exercise Price Range [Axis] Exercise Price 0.55 [Member] Exercise Price 2.00-3.85 [Member] Exercise Price 5.10-7.20 [Member] Exercise Price 0.55-7.20 [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Exclusive License Agreement [Member] Title of Individual [Axis] Dr. Brent Satterfield [Member] Debt Instrument [Axis] Robert Salna Promissory Note [Member] Long-term Debt, Type [Axis] Unsecured Debt [Member] Award Type [Axis] CAD [Member] Nine Employees [Member] Three Members Our Board of Directors [Member] Equity Components [Axis] Warrant [Member] Award Date [Axis] 2019 [Member] 2020 [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings (Deficit) [Member] Joint Venture Agreement [Member] Underwriting Agreement [Member] Legal Entity [Axis] WallachBeth Capital, LLC [Member] Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] Up to $1,000,000 [Member] $1,000,000-$2,000,000 [Member] $2,000,000-$3,000,000 [Member] Above $3,000,000 [Member] Financial Instrument [Axis] Robert Salna Promissory Note Payable [Member] Market Licensing Agreement [Member] Sales and Marketing [Member] Dr. Satterfield [Member] Range [Axis] Maximum [Member] Related Party [Axis] Two Companies [Member] Six Individuals and Four Companies [Member] Four Companies [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Investor [Member] Ownership [Axis] Beneficial Ownership [Member] Series A Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS: Current Assets Cash and cash equivalents Accounts receivable ,net Inventory Prepaid expenses Total current assets Property and equipment, net Investment in joint venture Total other long-term assets Total assets LIABILITIES AND STOCKHOLER'S EQUITY (DEFICIT): Current Liabilities Accounts payable Accrued expenses Accrued expenses (related party) Current notes payable net of $91,428 and $0 discount, respectively Deferred income current Total current liabilities Long-term Liabilities Accrued liabilities (related-party) Deferred income long-term Total long-term liabilities Total liabilities Commitments and contingencies STOCKHOLDERS' EQUITY (DEFICIT): Common stock, $.001 par value, 100,000,000 shares authorized; 12,923,383 and 12,317,184 shares issued and outstanding, respectively. Preferred stock, $.001 par value, 5,000,000 shares authorized Additional paid-in capital Accumulated deficit Total stockholders' equity (deficit) Total liabilities and stockholders' equity (deficit) Current notes payable related party, discount Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Income Statement [Abstract] Net sales Cost of sales Gross profit Operating expenses: Selling and marketing Administrative and general Research and development Depreciation and amortization Total operating expenses Total operating loss Other expense: Interest expense Interest income Loss on extinguishment of debt Net loss from investment in joint venture Total other expense Loss before income taxes Provision for income taxes Net loss Net loss per share - basic and diluted Weighted average shares - basic and diluted Statement [Table] Statement [Line Items] Beginning balance Beginning balance, shares Stock issued for cash, net of offering costs of $1,093,268 Stock issued for cash, net of offering costs of $1,093,268, shares Stock issued for debt retirement Stock issued for debt retirement, shares Stock-based compensation Stock-based compensation, shares Stock issued for exercise of warrants Stock issued for exercise of warrants, shares Net loss Ending balance Ending balance, shares Statement of Stockholders' Equity [Abstract] Stock offering cost Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Stock based compensation Accretion of notes payable discount Loss on extinguishment of debt Other losses Changes in assets and liabilities: Increase (decrease) deferred income Decrease (increase) in prepaid and other assets Increase in accounts receivable Increase in inventory Increase in accounts payable and accrued expenses Net cash used in operating activities Cash flows from investing activities: Purchase of property and equipment Investment in joint venture Net cash used by investing activities Cash flows from financing activities: Proceeds from equity financing Offering costs from equity financing Proceeds from warrant exercise Proceeds from debt financing Debt financing acquisition costs Principal payments on debt (related party) Net cash provided by financing activities Net increase (decrease) in cash Cash and cash equivalents beginning of period Cash and cash equivalents end of period Supplemental disclosure of cash flow information: Interest paid Income taxes paid Schedule of non-cash (investing) and financing activities: Common stock issued for convertible debt Accounting Policies [Abstract] Organization and Summary of Significant Accounting Policies Debt Disclosure [Abstract] Notes Payable Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-Based Compensation Insurance [Abstract] Lease Obligations Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Equity Income Tax Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Cash and Cash Equivalents Inventory Accounts Receivable Property and Equipment Equity-Method Investments Earnings (Loss) Per Share Stock-based Compensation Income Taxes Research and Development Use of Estimates Fair Value Measurements Patents and Intangibles Long-Lived Assets Customer Leased Equipment Revenue Recognition Related-Party Transactions Recently Issued Accounting Standards Schedule of Profits from Joint Venture Schedule of Notes Payable Schedule of Fair Values Options Weighted Average Assumptions Summary of Option Activity Schedule of Fair Values Warrants Assumptions Summary of Warrant Activity Summary of Stock Option and Warrant Outstanding Schedule of Unrecognized Stock-based Compensation Schedule of Lease Rent Obligations Schedule of Deferred Tax Assets Schedule of Income Tax Provision Investment in joint venture Interest rate Reimbursement expenses Reverse stock split Initial public offering, shares Common stock, price per share Commissions and non-accountable expense allowance, par value Exercisable period Additional shares of common stock to cover over-allotments Proceeds from issuance of initial public offering Net proceeds from initial public offering Debt principal amount Accrued interest Number of common stock issued Cash in excess of federal deposit insurance corporation Short-term deposits Potentially dilutive shares Research and development cost Patents and intangibles useful life Leased equipment description CDI Share Partner Share Current notes payable, discount Debt interest rate Debt maturity date Note repayable Debt principal payments Interest expense Debt note origination cost Interest expense for accretion Notes payable Total Less Current Portion Total Long-term Aggregate number of common shares reserved Unissued common stock options authorized shares Number of options granted Weighted average fair value of options granted Stock-based compensation expense related to granted Options granted, value Options vesting amount Warrants issued Weighted average fair value, warrant issued Number of common stock issued Exercise of warrants outstanding, shares Exercise of warrants outstanding Stock issued for consulting services, shares Stock issued for consulting services Stock repurchased during period, shares Stock repurchased during period, value Unrecognized stock-based compensation Risk free interest rate Expected life (in years) Expected volatility Expected dividend yield Stock price Options Outstanding, Beginning Options Outstanding, Option granted Options Outstanding, Expired Options Outstanding, Forfeited options Options Outstanding, Exercised Options Outstanding, Ending Weighted Average Exercise Price Outstanding, Beginning Weighted Average Exercise Price Options granted Weighted Average Exercise Price Expired Weighted Average Exercise Price Forfeited options Weighted Average Exercise Price Exercised Weighted Average Exercise Price Outstanding, Ending Weighted Average Fair Value Outstanding, Beginning Weighted Average Fair Value Options granted Weighted Average Fair Value Expired Weighted Average Fair Value Forfeited options Weighted Average Fair Value Exercised Weighted Average Fair Value Outstanding, Ending Weighted-average Remaining Contractual Life (years) Outstanding, Beginning Weighted-average Remaining Contractual Life (years) Options granted Weighted-average Remaining Contractual Life (years) Outstanding, Ending Warrant Outstanding, Beginning Warrant Outstanding, Warrants issued Warrant Outstanding, Expired Warrant Outstanding, Forfeited warrants Warrant Outstanding, Exercised Warrant Outstanding, Ending Weighted Average Exercise Price, Beginning Weighted Average Exercise Price, Warrant issued Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Forfeited warrants Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Ending Weighted Average Fair Value, Beginning Weighted Average Fair Value, Warrant issued Weighted Average Fair Value, Expired Weighted Average Fair Value, Forfeited warrants Weighted Average Fair Value, Exercised Weighted Average Fair Value, Ending Weighted-average Remaining Contractual Life (Years), Beginning Weighted-average Remaining Contractual Life (Years), Warrants issued Weighted-average Remaining Contractual Life (Years), Exercised Weighted-average Remaining Contractual Life (Years), Ending Range of Exercise Prices Range of Exercise Prices Number outstanding Weighted average remaining contractual life Weighted average exercise price Number exercisable Weighted average exercise price exercisable Total Area of land Contract lease per month Lease expiration date Rent expenses 2019 2020 Total Royalty payments, per month Equity funding Increase in Royalties Payable, per month Accrued royalties Research and development expense Due to related party Warrants to purchase of common stock Warrants exercisable price per share Aggregate value Number of warrants exercised Stock issued for services, shares Actual number of stock authorized to issue Conversion of debt Agency fees Sales of equity common stock Net operating loss carry-forwards Operating loss carry-forwards period Penalties or interest incurred NOL carry-forward Sec 179 carry-forwards Depreciation Valuation allowance Net deferred tax asset Book loss Depreciation Meals and entertainment Other non-deductible expenses Change in valuation allowance Income tax provision Number of common stock issued, value Purchase price paid Convertible note payable related parties Equity ownership percentage Sales of common stock price per shares Issuance of common stock gross proceeds Conversion of common stock converted Conversion of stock, amount converted Stock conversion price per share Exclusive License Agreement [Member] 0.11-0.55 [Member] 2.00-3.85 [Member] 0.11-7.20 [Member] 5.10-7.20 [Member] Summary of Stock Option and Warrant Outstanding [Table Text Block] 2015 Long-term Incentive Plan [Member] Options [Member] Warrants [Member] Outstanding Options [Member] Outstanding Warrants [Member] Schedule of Fair Values Warrants Assumptions [Table Text Block] CAD [Member] Nine Employees [Member] Options granted, value. Three Independent Members [Member] Three Members Our Board of Directors [Member] Options vesting amount. The number of equity-based payment instruments, excluding stock (or unit) options, that were Expired during the reporting period. The number of equity-based payment instruments, excluding stock (or unit) options, that were Exercised during the reporting period. Weighted average grant-date fair value of non-vested other than options outstanding. Share based compensation arrangement by share based payment award equity instruments other than options weighted average grant, Share based compensation arrangement by share based payment award equity instruments other than options weighted average Expired. Share based compensation arrangement by share based payment award equity instruments other than options weighted average forfeited. Share based compensation arrangement by share based payment award equity instruments other than options weighted average exercised. Share based compensation arrangement by share based payment award equity instruments other than options expired weighted average grant date fair value. Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible. Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. 2018 [Member] 2019 [Member] 2020 [Member] DNA Logix-Canada [Member] Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value. Dr. Brent Satterfield [Member] Stock issued for debt retirement. Stock issued for debt retirement, shares. Customer Leased Equipment [Policy Text Block] Related-Party Transactions [Policy Text Block] Joint Venture Agreement [Member] Commissions and non-accountable expense allowance, par value. Underwriting Agreement [Member] WallachBeth Capital, LLC [Member] Net proceeds from initial public offering. Up to $1,000,000 [Member] $1,000,000-$2,000,000 [Member] $2,000,000-$3,000,000 [Member] Above $3,000,000 [Member] CDI share. Partner share. Convertible Promissory Note [Member] Stock issued for exercise of warrants. Stock issued for exercise of warrants, shares. Leased equipment description. Robert Salna Promissory Note [Member] Robert Salna Promissory Note Payable [Member] Market Licensing Agreement [Member] Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible. Exercise of warrants outstanding. Exercise of warrants outstanding, shares. Dr. Satterfield [Member] Equity funding. This element represent warrants to purchase of common stock. Two Companies [Member] Six Individuals and Four Companies [Member] Agency fees. Four Companies [Member] Operating loss carry-forwards period. Deferred tax asset depreciation. Penalties or interest incurred. Actual number of stock authorized to issue. Series A Convertible Preferred Stock [Member] Beneficial Ownership [Member] Interest expense for accretion. Sales and Marketing [Member] Weighted-average Remaining Contractual Life (years) Options granted. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Purchase price paid. Stock conversion price per share. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Other Other Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Deferred Income Taxes Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Interest in Joint Venture Net Cash Provided by (Used in) Investing Activities Payments of Debt Restructuring Costs Payment of Financing and Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Inventory, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Long-term Debt, Excluding Current Maturities Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.11-7.20 [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Operating Leases, Future Minimum Payments Due Deferred Tax Assets, Valuation Allowance Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation, Amount